Michael Biermer, Thomas Berg  Gastroenterology 

Slides:



Advertisements
Similar presentations
Increased Levels of Arginase in Patients With Acute Hepatitis B Suppress Antiviral T Cells Elena Sandalova, Diletta Laccabue, Carolina Boni, Tsunamasa.
Advertisements

Classification of virologic responses based on outcomes during and after a 48-week course of pegylated interferon (PEG IFN) plus ribavirin antiviral therapy.
Classification of virologic responses based on outcomes during and after a 48-week course of pegylated interferon (PEG IFN) plus ribavirin antiviral therapy.
Volume 149, Issue 6, Pages (November 2015)
Rapid virological response tailors the duration of treatment in hepatitis C virus genotype 3 patients treated with pegylated interferon alfa-2a and ribavirin.
Which patients with genotype 1 chronic hepatitis C can benefit from prolonged treatment with the ‘accordion’ regimen?  Patrick Marcellin, E. Jenny Heathcote,
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals  Susanna Naggie, Mark S. Sulkowski  Gastroenterology 
Volume 129, Issue 5, Pages (November 2005)
Volume 132, Issue 4, Pages (April 2007)
Pure red cell aplasia following pegylated interferon α treatment
Covering the Cover Gastroenterology
Volume 149, Issue 6, Pages (November 2015)
Volume 140, Issue 3, Pages e3 (March 2011)
The prevalence of alcohol-induced liver disease and hepatitis C and their interaction in a tertiary care setting  Adnan Said, John Williams, Jeremy Holden,
Volume 153, Issue 4, Pages (October 2017)
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 59, Issue 4, Pages (October 2013)
Volume 142, Issue 4, Pages (April 2012)
Volume 134, Issue 5, Pages (May 2008)
Volume 155, Issue 5, Pages e2 (November 2018)
Jean-Michel Pawlotsky  Gastroenterology 
Volume 141, Issue 5, Pages (November 2011)
Early Virologic Responses and Hematologic Safety of Direct-Acting Antiviral Therapies in Veterans With Chronic Hepatitis C  Pamela S. Belperio, Elizabeth.
A. Sidney Barritt, Michael W. Fried  Gastroenterology 
Volume 130, Issue 4, Pages (April 2006)
Incidence of Statin Hepatotoxicity in Patients With Hepatitis C
Update on the Use of Vonoprazan: A Competitive Acid Blocker
Volume 135, Issue 5, Pages (November 2008)
Effectiveness of interferon α-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice1   Thomas.
Volume 142, Issue 6, Pages (May 2012)
Volume 141, Issue 1, Pages (July 2011)
Volume 139, Issue 1, Pages e4 (July 2010)
Volume 144, Issue 7, Pages e2 (June 2013)
Rafael Esteban, Maria Buti  Gastroenterology 
Volume 136, Issue 5, Pages (May 2009)
Chronic Hepatitis C Therapy: Changing the Rules of Duration
Volume 140, Issue 7, Pages (June 2011)
Interleukin-28b: A Key Piece of the Hepatitis C Virus Recovery Puzzle
Volume 152, Issue 1, Pages (January 2017)
Covering the Cover Gastroenterology
Volume 132, Issue 1, Pages 5-6 (January 2007)
Volume 148, Issue 3, Pages (March 2015)
Genetic Factors and Hepatitis C Virus Infection
Volume 123, Issue 4, Pages (October 2002)
Volume 138, Issue 3, Pages e1 (March 2010)
Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?  Lawrence.
Statin Therapy Improves Sustained Virologic Response Among Diabetic Patients With Chronic Hepatitis C  Gowtham A. Rao, Prashant K. Pandya  Gastroenterology 
The Dawning of a New Editorial Board for Gastroenterology
Volume 136, Issue 5, Pages e2 (May 2009)
Timothy P. Sheahan, Charles M. Rice  Gastroenterology 
Alessio Aghemo, Maria Francesca Donato  Gastroenterology 
Hepatitis C treatment in patients with kidney disease
This Month in Gastroenterology
Changing of the Guards: 2011–2016 Gastroenterology Team
Yun-Fan Liaw, Wen-Juei Jeng, Ming-Ling Chang  Gastroenterology 
Volume 130, Issue 7, Pages (June 2006)
Michelle Maria Pietzak  Gastroenterology 
Julia Lörke, Andreas Erhardt, Dieter Häussinger 
Volume 155, Issue 6, Pages (December 2018)
Volume 139, Issue 6, Pages e1 (December 2010)
Volume 139, Issue 5, Pages (November 2010)
Volume 147, Issue 6, Pages (December 2014)
Covering the Cover Gastroenterology
U.P. Neumann, M. Biermer, D. Eurich, P. Neuhaus, T. Berg 
Detection of HCV RNA in Sustained Virologic Response to Direct-Acting Antiviral Agents: Occult or Science Fiction?  Masaru Enomoto, Yoshiki Murakami,
Volume 124, Issue 3, Pages (March 2003)
Controversies in Liver Transplantation for Hepatitis C
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus.
Presentation transcript:

Rapid Suppression of Hepatitis C Viremia Induced by Intravenous Silibinin Plus Ribavirin  Michael Biermer, Thomas Berg  Gastroenterology  Volume 137, Issue 1, Pages 390-391 (July 2009) DOI: 10.1053/j.gastro.2009.02.087 Copyright © 2009 Terms and Conditions

Figure 1 HCV RNA decline during the staggered treatment course of ribavirin, silibinin, and pegylated interferon-alfa in a cirrhotic patient who failed previous antiviral therapy (as measured by TaqMan real-time polymerase chain reaction and TMA assay at day 17). Gastroenterology 2009 137, 390-391DOI: (10.1053/j.gastro.2009.02.087) Copyright © 2009 Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.